On August 18, 2021, the Ministry of Health issues the Decision No. 3982/QD-BYT promulgating the Interim Guidance for the prevention and treatment of COVID-19 caused by the SARS-CoV-2 virus in pregnant women and newborns.
Accordingly, a pregnant woman infected with COVID-19 shall receive treatment for COVID-19 first, obstetric intervention shall be carried out only when there is an emergency obstetric symptom or when her condition is severe and requires consultation with relevant specialists. A COVID-19-infected pregnant woman whether cured or not, shall be managed every 2 to 4 weeks for early detection of preeclampsia, intrauterine growth retardation, and threatened preterm/preterm birth.
Besides, a newborn from a mother infected or suspected of being infected with COVID-19 shall be tested for COVID-19 infection. To be specific: A newborn from an infected mother shall be tested for the first time when he/she is 2 to 24 hours old, his/her face should be washed or wiped before sampling, sampling site: throat or nose; then he/she shall be tested for the second time when he/she is 48 hours old, the third and fourth tests shall be carried out when he/she is 7 and 14 days old, respectively. For a newborn in close contact with an infected person or his/her mother who is infected after birth: procedures for diagnosis and monitoring are the same as those applicable to adults.
In addition, where conditions are limited, priority should be given to test newborns with symptoms of COVID-19 as well as newborns exposed to SARS-CoV-2 requiring care at intensive care unit or expected for prolonged hospitalization.
This Decision takes effect on the signing date.